Grant: Doctoral Award - Doctoral Foreign Study Award (DFSA)
Direct Payment
$105,000.00
Investigation of Telomere Movement, Clustering and Recombination in Telomerase-negative Cancer Cells
FY 2012-13
Summary
Telomeres, or the natural end of chromosomes, continue to shorten with each cell division. Because a cell cannot survive with critically short telomeres, they provide protection against cancerous cells that proliferate indiscriminately. Often, an enzyme called telomerase is activated in cancers to elongate short telomeres. Some tumours, however, lack the activation of telomerase. These types of tumours, which are particularly common in pediatric brain cancer and pancreatic cancer patients, use an alternative mechanism, termed ALT (Alternative Lengthening of Telomeres), to lengthen and maintain their telomeres in order to achieve immortality.
Strikingly, preliminary results forming the basis of this research proposal indicate that telomere elongation in ALT cells occurs via a process in which separate telomeres show increased mobility in the nucleus and eventually join in with each other. It is thought that in these clusters, they use homologous recombination, or a "copy-and-paste" mechanism where telomeric sequences are used as template for elongation at another telomere. The main goals of this study are to further understand the mechanism through which this process occurs and to identify factors that are required for ALT.
Importantly, additional preliminary screening data has identified a promising enzyme whose loss prevents telomeric clustering in ALT cells and increases cell death. If further validated, this represents a potential window for targeted cancer therapy against tumours that rely on ALT. In addition to the tumours that originally use ALT, it was recently discovered that other tumours treated with telomerase inhibitors can develop resistance by adopting the ALT pathway. The value in this proposal lies in the potential to discover the first available ALT-specific therapy, as well as to improve current therapeutic strategy targeting telomerase by preventing resistance.
Department
Program
Doctoral Award - Doctoral Foreign Study Award (DFSA)
Recipient
Location
Pennsylvania, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
283769
Name
Cho Nam Woo
Region
Pennsylvania
Country
United States of America
Orgtype
Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Investigation of Telomere Movement, Clustering and Recombination in Telomerase-negative Cancer Cells
Programtype2
Studentship Programs
Orgnameinp2
Direct Payment
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Doctoral Foreign Study Award (DFSA)
Keyworddelim
Alternative Lengthening Of Telomeres; Chromatin Immunoprecipitation; Chromatin Regulation Of Dna Repair; Chromatin Regulation Of Telomeres; Fluorescence In Situ Hybridization; Live Cell Microscopy; Telomere Regulation In Cancer; Therapeutic Inhibition Of Telomere Elongation; Transcription-Dependent Chromatin Movement
Abstract
Telomeres, or the natural end of chromosomes, continue to shorten with each cell division. Because a cell cannot survive with critically short telomeres, they provide protection against cancerous cells that proliferate indiscriminately. Often, an enzyme called telomerase is activated in cancers to elongate short telomeres. Some tumours, however, lack the activation of telomerase. These types of tumours, which are particularly common in pediatric brain cancer and pancreatic cancer patients, use an alternative mechanism, termed ALT (Alternative Lengthening of Telomeres), to lengthen and maintain their telomeres in order to achieve immortality.
Strikingly, preliminary results forming the basis of this research proposal indicate that telomere elongation in ALT cells occurs via a process in which separate telomeres show increased mobility in the nucleus and eventually join in with each other. It is thought that in these clusters, they use homologous recombination, or a "copy-and-paste" mechanism where telomeric sequences are used as template for elongation at another telomere. The main goals of this study are to further understand the mechanism through which this process occurs and to identify factors that are required for ALT.
Importantly, additional preliminary screening data has identified a promising enzyme whose loss prevents telomeric clustering in ALT cells and increases cell death. If further validated, this represents a potential window for targeted cancer therapy against tumours that rely on ALT. In addition to the tumours that originally use ALT, it was recently discovered that other tumours treated with telomerase inhibitors can develop resistance by adopting the ALT pathway. The value in this proposal lies in the potential to discover the first available ALT-specific therapy, as well as to improve current therapeutic strategy targeting telomerase by preventing resistance.
Competitiondate
201210
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Cho, Nam Woo
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~